Meeting Objectives:
-
-
Identify unmet needs and recent trends in the management of patients with chronic lymphocytic leukemia (CLL).
-
Using real-world patient cases, analyze recent guideline updates and new clinical trial data on bruton kinase inhibitors (BTKi) to make informed, personalized recommendations for patients with CLL.
-
Discuss the integral role of pharmacists in the care of patients with CLL on BTKi, including optimizing patient selection, education, and monitoring, along with strategies to enhance medication access and adherence.
-
Share This Event